香川県ゲーム条例の騒動を思い出した。
RT @syuichiao89: 薬物治療も含め、健康寿命とかいうアウトカムに対する介入の効果は、高齢であればあるほど限定的であることをまずは知らなけれななりません。 Effect of Aspirin on Disability-free Survival in the H…
薬物治療も含め、健康寿命とかいうアウトカムに対する介入の効果は、高齢であればあるほど限定的であることをまずは知らなけれななりません。 Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/ZGwgxotDpv
New england Journal of Medicine'de yayınlanan " Aspirin'in Sağlıklı Yaşlılarda Engelli Olmadan Hayatta Kalma Üzerindeki Etkisi " başlıklı araştırması https://t.co/EH1P9l2zuG
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaH98c
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
@dreamcasting76 @MattMcInnis6 @Dave1again This site is really good https://t.co/F4ey33MPcZ Like, I fail to see where there is any problem. Daily Aspirin therapy has a MUCH worse safety profile and people still think it is a good idea. https://t.co/iSSanwr
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaZimk
So it seems aspirin is not everything it was made out to be? https://t.co/gPuFibTWaK… #breatheagain #riteshbawri #the100next
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
RT @AnswersinCME: Interesting data: #Aspirin use in healthy elderly persons did not prolong disability-free survival but led to a higher ra…
Interesting data: #Aspirin use in healthy elderly persons did not prolong disability-free survival but led to a higher rate of major hemorrhage than placebo in the #ASPREE trial over 5 years https://t.co/upD3po64Pg
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
New post in Development of Pharmacy Channel: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/Xi9EFfTXhG https://t.co/Jk83zzolIJ
Según 3 artículos publicados en NEJM con ensayos clínicos en >19,000 pacientes: Aspirina se asocia con mayor mortalidad por todas las causas, cancer y más sangrado en ancianos mayores de 60 años. 👉 https://t.co/ImnTZgTCgB
RT @Mirella_PhD: New Study of Daily Low Dose Asprin in Persons >70 - Found it to be Harmful 📰 "Aspirin use in healthy elderly persons did…
RT @Dr_Khan: 3rd “Nail in the Coffin“ for Aspirin in Primary Prevention .. ARRIVE in moderate risk individuals, ASCEND in diabetics, now AS…
RT @Dr_Khan: 3rd “Nail in the Coffin“ for Aspirin in Primary Prevention .. ARRIVE in moderate risk individuals, ASCEND in diabetics, now AS…
3rd “Nail in the Coffin“ for Aspirin in Primary Prevention .. ARRIVE in moderate risk individuals, ASCEND in diabetics, now ASPREE in healthy elderly fails to show benefit of 100mg/d coated Aspirin. https://t.co/L9OuqxR40j #CardioTwitter https://t.co/rqtzy
RT @bircis: ASPİRİN! https://t.co/zSRdHHFpH7
RT @bircis: ASPİRİN! https://t.co/zSRdHHFpH7
RT @bircis: ASPİRİN! https://t.co/zSRdHHFpH7
ASPİRİN! https://t.co/zSRdHHFpH7
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
@davidasinclair See also: «Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo.» https://t.co/Hzo0Cs409K
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
RT @KetoedSaudi: دراسة الـ: ▫️عينتان، عينة تأخذ ١٠٠ ملقم من الآسبرين كل يوم، وعينة لا. نتائج الدراسة: العينة المستهلكة لـ ١٠٠ ملقم من الأ…
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaH98c
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
RT @Dr_Khan: 3rd “Nail in the Coffin“ for Aspirin in Primary Prevention .. ARRIVE in moderate risk individuals, ASCEND in diabetics, now AS…
RT @Dr_Khan: 3rd “Nail in the Coffin“ for Aspirin in Primary Prevention .. ARRIVE in moderate risk individuals, ASCEND in diabetics, now AS…
RT @Dr_Khan: 3rd “Nail in the Coffin“ for Aspirin in Primary Prevention .. ARRIVE in moderate risk individuals, ASCEND in diabetics, now AS…
3rd “Nail in the Coffin“ for Aspirin in Primary Prevention .. ARRIVE in moderate risk individuals, ASCEND in diabetics, now ASPREE in healthy elderly fails to show benefit of 100mg/d coated Aspirin. https://t.co/L9Ouqy8FoT https://t.co/qxkwWcsFn4
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
"Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo." https://t.co/dFc1fpt3Mz
@ChrisallenAllen Nope it kills you with major haemorrhage. The same group looked to see if it prevents disability free survival (it doesn’t). Turns out the elixir of life isn’t willow bark (but I have some magic beans going cheap) https://t.co/RNF99nspEe
RT @NEJM: The ASPREE trials: #Aspirin and Disability-free Survival in Healthy Elderly https://t.co/QUFKIcTuPI Effect of Aspirin on All-Ca…
RT @journalclubju: نسعد بمعرفة رغبتكم تجاه المقالة العلمية التي تودون منا مناقشتها في اللقاء القادم من برنامج #Journal_Club_JU في تخصص طب…
RT @journalclubju: نسعد بمعرفة رغبتكم تجاه المقالة العلمية التي تودون منا مناقشتها في اللقاء القادم من برنامج #Journal_Club_JU في تخصص طب…
RT @journalclubju: نسعد بمعرفة رغبتكم تجاه المقالة العلمية التي تودون منا مناقشتها في اللقاء القادم من برنامج #Journal_Club_JU في تخصص طب…
RT @journalclubju: نسعد بمعرفة رغبتكم تجاه المقالة العلمية التي تودون منا مناقشتها في اللقاء القادم من برنامج #Journal_Club_JU في تخصص طب…
RT @journalclubju: نسعد بمعرفة رغبتكم تجاه المقالة العلمية التي تودون منا مناقشتها في اللقاء القادم من برنامج #Journal_Club_JU في تخصص طب…
نسعد بمعرفة رغبتكم تجاه المقالة العلمية التي تودون منا مناقشتها في اللقاء القادم من برنامج #Journal_Club_JU في تخصص طب الأسرة والمجتمع - #FamilyMedicine المقالة الأولى: https://t.co/BVnwMqr7Uu المقالة الثانية: https://t.co/rlv9gJx3VT
RT @Luke_629: Effect of Aspirin on Disability-free Survival in the Healthy Elderly アスピリンは障害のない期間を延長しない。NEJM https://t.co/EOHOkadWNP
Effect of Aspirin on Disability-free Survival in the Healthy Elderly アスピリンは障害のない期間を延長しない。NEJM https://t.co/EOHOkadWNP
@US_FDA One of the 3 recent major studies - also dementia, etc. in other studies. CONCLUSIONS Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placeb
ASPREE - 2018 - Aspirin vs placebo in healthy over 70s - ∅mortality, dementia, disability ↑clinically significant bleedinh - https://t.co/5uU7eaYKwM
@sickendun2death @olejonbj @melabroohaha @DeniseShearin @GeoffRBennett Did you know Asprin kills 3000 a year. That's more than will die from Covid19 in California. Why don't you get on the Asprin folks https://t.co/HtzWLTSI00
RT @syuichiao89: 健常高齢者におけるアスピリンの使用は、5年間にわたって障害のない生存期間を延長せず出血が多い Effect of Aspirin on Disability-free Survival in the Healthy Elderly. - Pub…
健常高齢者におけるアスピリンの使用は、5年間にわたって障害のない生存期間を延長せず出血が多い Effect of Aspirin on Disability-free Survival in the Healthy Elderly. - PubMed - NCBI https://t.co/oKFdae80Xp
RT @BasiaDiug: What the @ASPREE_aus didn’t expect was an increase in cancer mortality. This is not meant to happen with a drug being taken…
Ground rounds today is the place to be @JohnMcNeil6. A great insight into @ASPREE_aus and going forward more medical students have an opportunity to will be part of it from 2020 as part to the MD Scholarly Intensive Placement @Monash_FMNHS @Monash_SPHPM
What the @ASPREE_aus didn’t expect was an increase in cancer mortality. This is not meant to happen with a drug being taken as a form of prevention says @JohnMcNeil6. A real concern when aspirin is a potential preventive agent for bowel cancer. https://t.c
دراسة الـ: ▫️عينتان، عينة تأخذ ١٠٠ ملقم من الآسبرين كل يوم، وعينة لا. نتائج الدراسة: العينة المستهلكة لـ ١٠٠ ملقم من الأسبرين كل يوم عانوا من: ١ - الـ Hemorrhage "النزيف الداخلي". ٢ - زيادة الـ All Cause Mortality "الوفاة من أي مسبب". https://t.co/OV1NW
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @drmurataksoy: Herkes aspirin kullanmalı mı sorusunun cevabı yeni bir çalışmada verildi: Bir hastalığı olmayan kişilerde aspirin kullanı…
RT @drmurataksoy: Herkes aspirin kullanmalı mı sorusunun cevabı yeni bir çalışmada verildi: Bir hastalığı olmayan kişilerde aspirin kullanı…
RT @drmurataksoy: Herkes aspirin kullanmalı mı sorusunun cevabı yeni bir çalışmada verildi: Bir hastalığı olmayan kişilerde aspirin kullanı…
Herkes aspirin kullanmalı mı sorusunun cevabı yeni bir çalışmada verildi: Bir hastalığı olmayan kişilerde aspirin kullanımı yarar getirmiyor. https://t.co/b3GQgPVDJC
Breaking news! https://t.co/qK7vPCr82j
RT @MSSNYRothberg: ‘Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a h…
RT @dpdevore: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM - https://t.co/vNYgH1yMUG https://t.co/Oo2aHlCsxo
Large clinical trial shows that daily low dose aspirin prescribed to healthy, older patients has no benefit but does increase likelihood of hemorrhage. https://t.co/MGFsRKpIpg
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM - https://t.co/vNYgH1yMUG https://t.co/Oo2aHlCsxo
‘Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo’. https://t.co/r8J5nNBLjC
RT @drcadesky: Aspirin (ASA): still not a cure all. This study shows that it does not improve quality of length of life in older men https:…
Aspirin (ASA): still not a cure all. This study shows that it does not improve quality of length of life in older men https://t.co/AIY5LlkMG4
RT @NEJM: Original Article: Effect of #Aspirin on Disability-free Survival in the Healthy Elderly (ASPREE) https://t.co/QUFKIcTuPI https://…
RT @DocMedia3: #docmediacardiologia . Benefício zero na prevenção primária com ácido acetilsalicílico . Quer saber mais? . https://t.co/oMK…
RT @ibrahimsarbay: Sağlıklı yaşlı hastalarda, kalp hastalıklarından korunmak için “bebek aspirini” kullanmanın yararının olmadığı, hatta za…
Sağlıklı yaşlı hastalarda, kalp hastalıklarından korunmak için “bebek aspirini” kullanmanın yararının olmadığı, hatta zararının olduğu görülmüş. https://t.co/27NTRGZukS #makalesaati https://t.co/oFyAF41Zn1
Effect of Aspirin on Disability-free Survival in the Healthy Elderly. - PubMed - NCBI https://t.co/tTzDkyBnZ8
In healthy older adults, aspirin did not affect disability-free survival or CVD but increased death and bleeding #ACPJC https://t.co/0J93WNI5To
RT @NathanStall: 1. ASPREE trials via @NEJM: aspirin for primary prevention in older adults. Aspirin had no effect on disability-free survi…
RT @NathanStall: 1. ASPREE trials via @NEJM: aspirin for primary prevention in older adults. Aspirin had no effect on disability-free survi…
RT @NathanStall: 1. ASPREE trials via @NEJM: aspirin for primary prevention in older adults. Aspirin had no effect on disability-free survi…
RT @NathanStall: 1. ASPREE trials via @NEJM: aspirin for primary prevention in older adults. Aspirin had no effect on disability-free survi…
1. ASPREE trials via @NEJM: aspirin for primary prevention in older adults. Aspirin had no effect on disability-free survival (https://t.co/ddjGtx1Oxj) and cardiovascular events (https://t.co/KgJNHnn8nK) while increasing bleeding and all-cause mortality (h
RT @EricTopol: When low-dose aspirin is not only a bust, but is associated with higher all-cause mortality, #cancer, and more bleeding in h…